Connect with others who understand.

sign up log in
Resources
About mySMAteam

Connect with others who understand.

sign up log in
Resources
About mySMAteam

Treatment Options for Adults with SMA

Updated on September 16, 2022
Medically reviewed by
Joseph V. Campellone, M.D.
Article written by
Kelly Crumrin

  • About one-third of people with spinal muscular atrophy (SMA) are adults.
  • Adults with SMA may have a hard time accessing effective health care, and many disengage from the health care system.
  • Treatment can benefit adults with SMA by improving quality of life and addressing complications associated with aging.

More than one-third of people with spinal muscular atrophy (SMA) — 35 percent — are adults. Among adults with SMA, most have SMA type 3 (Kugelberg-Welander syndrome). Type 4, also known as adult-onset SMA, is the mildest type of SMA. Since SMA type 4 is extremely rare, there is little research and information about the condition available.

Even among adults with the more common type 3 SMA, the medical community has a poor understanding about how adults experience the condition. However, in one small study of 25 adults or family members of adults with type 3 SMA in Australia, researchers found that participants commonly had major gaps in health care and a perceived low value for the health care they received. The majority of participants described difficulties around finding and accessing specialists and clinics capable of treating adults with SMA. Those who expressed a low value for their health care reported encountering health care providers who weren’t knowledgeable about SMA. Other adults with SMA who had stable symptoms were not motivated to seek care. For these and other reasons, many participants had disengaged from the health care system.

Read more about Tips for Staying on Spinal Muscular Atrophy Therapies.

Accessing Treatment for Later-Onset SMA

For those diagnosed with SMA as children, there may not be an effective program to support the transition to adult care. It can be difficult to find and access a specialist or clinic that offers multidisciplinary care for adults with SMA.

According to nonprofit advocacy group Cure SMA, the recommended standard of care for SMA differs in some ways between adults and children. Adults are more involved in decision-making and more likely to experience medical problems involving multiple body systems. For adults and children with SMA alike, it’s recommended to have a multidisciplinary health care team including a central provider who coordinates medication, acute care, physical therapy, and specialists in neuromuscular, pulmonary, gastrointestinal, and orthopedic care.

Cure SMA offers a Find a Location search in the U.S. with an “adult site” option. Despite the challenges many adults with SMA have experienced in accessing care, it is worth noting that the field of SMA care is rapidly changing as new treatments are approved and others are being researched. As treatments are added, access will likely expand.

Treatments for Adult-Onset SMA

As of October 2022, nusinersen (Spinraza) and risdiplam (Evrysdi) are the only medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of spinal muscular atrophy in adults as well as children.

Researchers are beginning to focus on finding effective treatments for adults living with spinal muscular atrophy. There are also a number of clinical trials — recently completed, ongoing, or planned — to study the safety and effectiveness of new treatments in adults with spinal muscular atrophy. In addition to Spinraza, ClinicalTrials.gov lists studies for several other investigative treatments specifically for adults with SMA:

  • 4-aminopyridine
  • Risdiplam
  • Pyridostigmine
  • Reldesemtiv
  • Olesoxime

Other Benefits To Seeking Treatment

Whether or not an adult with SMA decides to take Spinraza or enroll in a clinical trial for access to a new treatment, engaging with health care can provide many benefits. An adult provider can act as a care coordinator, making referrals and connecting you with specialists as needed.

An adult provider who understands SMA can also help navigate the aging process, screening for diseases that become more common as people get older. For instance, cardiovascular disease is not only the number one cause of death around the world, but frequently a related condition in SMA. As the needs of an adult with SMA change, an adult provider can help coordinate with specialists or admit to nonpediatric hospitals if necessary.

Psychological health is also important — one study found a connection between emotional distress and health-related quality of life in people with SMA. An adult provider can help identify depression, discuss whether antidepressant medication may help, and refer adults with SMA to a mental health provider.

For those with later-onset SMA, finding a knowledgeable and supportive health care provider is an important part of Staying Your Healthiest With SMA.

References
  1. Verhaart I, Robertson A, Leary R, McMacken G, König K, Kirschner J, et al. A multi source approach to determine sma incidence and research ready population. J Neurol. 2017;264:1465–73.
  2. Qian, Y., McGraw, S., Henne, J., Jarecki, J., Hobby, K., & Yeh, W. S. (2015). Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study. BMC Neurology, 15, 217. https://doi.org/10.1186/s12883-015-0473-3
  3. SMA Overview. (PDF.) Cure SMA. Retrieved February 2020, from http://www.smafoundation.org/wp-content/uploads/2012/03/SMA-Overview.pdf
  4. Wan, H.W.Y., Carey, K.A., D’Silva, A. et al. “Getting ready for the adult world”: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being. Orphanet J Rare Dis 14, 74 (2019). Accessed at https://doi.org/10.1186/s13023-019-1052-2
  5. Elsheikh, B., & Duong, T. (n.d.). Medical Management of Adults with SMA. In Cure SMA meeting, Dallas, Texas, June 2018. Retrieved from https://www.curesma.org/wp-content/uploads/2019/07/adult-med-management-conf2018-presentation.pdf
  6. Spinal muscular atrophy type 4. (n.d.). Genetic and Rare Diseases Information Center (GARD). Retrieved February 2020, from https://rarediseases.info.nih.gov/diseases/564/spinal-muscular-atrophy-type-4
  7. Gidaro, T., & Servais, L. (2018). Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps. Developmental Medicine & Child Neurology, 61(1), 19–24. doi: 10.1111/dmcn.14027. Accessed at https://onlinelibrary.wiley.com/doi/full/10.1111/dmcn.14027
  8. Search of: spinal muscular atrophy: Adult - Search Details. (n.d.). ClinicalTrials.gov. Retrieved February 17, 2020, from https://clinicaltrials.gov/ct2/results/details?cond=spinal+muscular+atrophy&age=1searched on 2/17/2020 for “adult” and “spinal muscular atrophy)
  9. Kruitwagen-Van Reenen ET, Wadman RI, Visser-Meily JM, van den Berg LH, Schröder C, van der Pol WL. Correlates of health related quality of life in adult patients with spinal muscular atrophy. Muscle Nerve. 2016;54:850–5. Accessed at https://onlinelibrary.wiley.com/doi/abs/10.1002/mus.26201
All updates must be accompanied by text or a picture.
Joseph V. Campellone, M.D. is board-certified in neurology, neuromuscular disease, and electrodiagnostic medicine. Review provided by VeriMed Healthcare Network. Learn more about him here.
Kelly Crumrin is a senior editor at MyHealthTeam and leads the creation of content that educates and empowers people with chronic illnesses. Learn more about her here.

Related articles

Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...

Tips for Staying on Spinal Muscular Atrophy (SMA) Therapies

Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...
Spinal muscular atrophy (SMA) is a neuromuscular disorder that causes muscle weakness throughout...

Respiratory Equipment for SMA: What To Look For

Spinal muscular atrophy (SMA) is a neuromuscular disorder that causes muscle weakness throughout...
Until very recently, treatments for spinal muscular atrophy (SMA) could only manage symptoms....

Treatments for Spinal Muscular Atrophy (SMA)

Until very recently, treatments for spinal muscular atrophy (SMA) could only manage symptoms....
Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...

Understanding How SMA Gene Therapy Works

Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...
Physical therapy can help manage symptoms of SMA like contractures or scoliosis.There are...

Physical Therapy for SMA: How To Get the Most Out of PT

Physical therapy can help manage symptoms of SMA like contractures or scoliosis.There are...
Spinal muscular atrophy (SMA) is a genetic disease that destroys nerve cells in the spinal cord...

The Importance of Splicing in SMA Treatment

Spinal muscular atrophy (SMA) is a genetic disease that destroys nerve cells in the spinal cord...

Recent articles

Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...

5 Reasons To Consider Participating in SMA Clinical Trials

Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...
Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...

How Do Clinical Trials Work for SMA?

Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...
Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...

Are Clinical Trials Safe for People With SMA?

Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...
The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...

UCSF Health and mySMAteam Partnership: SMA Awareness Month 2022

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...
The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...

What People With SMA Should Know About Getting a Second COVID-19 Booster Shot

The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...
Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...

Learning Self-Advocacy at a Young Age: My Experiences

Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...
mySMAteam My spinal muscular atrophy Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close